Instrument Inactif

Communiqués Cubist Pharmaceuticals Inc

Actions

US2296781071

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

09/12/14	Merck : compte toujours acheter Cubist malgré un souci sur le Cubicin	RE
08/12/14	Cubist Pharmaceuticals : Merck & Co acquiert Cubist Pharma pour 8,4 milliards de dollars	RE

Communiqués

13/01/15	Cubist Pharmaceuticals : Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market	BU
20/12/14	Cubist Pharmaceuticals : annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des infections urinaires compliquées et des infections intra-abdominales compliquées	BU
20/12/14	Cubist Pharmaceuticals : Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract and Complicated Intra-abdominal Infections	BU
16/12/14	Cubist Pharmaceuticals : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company	PR
12/12/14	Cubist Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU
12/12/14	Cubist Pharmaceuticals : CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Merck & Co.	BU
11/12/14	CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
10/12/14	Cubist Pharmaceuticals : CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co.	BU
09/12/14	Cubist Pharmaceuticals : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. -- CBST	PR
09/12/14	Cubist Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Cubist Pharmaceuticals Inc.	PR
09/12/14	Cubist Pharmaceuticals : Harwood Feffer LLP : Announces Investigation of Cubist Pharmaceuticals Inc.	PR
09/12/14	Cubist Pharmaceuticals : Comments on CUBICIN Patent Litigation	BU
08/12/14	Cubist Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU
08/12/14	CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc.	BU
08/12/14	Cubist Pharmaceuticals : Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Merck	PR
08/12/14	Cubist Pharmaceuticals : Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Cubist Pharmaceuticals Inc. Concerning its Proposed Sale to Merck & Co. -CBST	PR
08/12/14	CUBIST PHARMACEUTICALS : ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Cubist Pharmaceuticals, Inc. to Merck	BU
17/11/14	Cubist Pharmaceuticals : European Antibiotic Awareness Day Highlights Need for Urgent Action	PU
17/11/14	Cubist Pharmaceuticals : La journée européenne d’information sur les antibiotiques souligne le besoin d’une action urgente	BU
05/11/14	Cubist Pharmaceuticals : Names Dr. Patrick Vink Chief Operating Officer	BU
03/11/14	Cubist Pharmaceuticals : to Present at Jefferies 2014 Healthcare Conference	BU
21/10/14	Cubist Pharmaceuticals : Reports Third Quarter 2014 Financial Results	BU
21/10/14	Cubist Pharmaceuticals : Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma	PR
20/10/14	Cubist Pharmaceuticals : Names Robert J. Perez Chief Executive Officer	BU
14/10/14	Cubist Pharmaceuticals : to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014	BU